import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "peptide-research-documentation-lab-notebook-guide",
  title: "Research Documentation for Peptide Studies: Lab Notebook Best Practices",
  description:
    "How to structure research documentation for peptide studies — experiment logs, COA records, reconstitution calculations, dose-tracking tables, and data integrity practices that withstand scientific scrutiny.",
  category: "Research Fundamentals",
  readMinutes: 9,
  publishedAt: "2026-06-07",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "Good research documentation is not bureaucratic overhead — it is what separates a reproducible experiment from an anecdote. In peptide research, where compound stability, reconstitution variables, and dose timing all affect outcomes, meticulous records are an active part of experimental rigor. A well-kept lab notebook allows another researcher to replicate your conditions exactly, allows you to trace anomalies to their source, and forms the chain of custody that connects your raw data to your conclusions.",
    },
    {
      type: "paragraph",
      text: "This guide covers the core elements of research documentation for peptide studies: what to record before, during, and after each experiment, how to structure reconstitution and dose logs, how to handle COA documentation, and how to manage data in ways that preserve integrity over time.",
    },
    {
      type: "heading",
      text: "The Pre-Experiment Record",
    },
    {
      type: "paragraph",
      text: "Before a single animal is dosed or a cell plate is treated, the following should be documented: the study hypothesis, the compound(s) being used with full specification (name, source, lot number, stated purity, COA date), the vehicle and reconstitution plan, the dosing schedule and route of administration, the sample size rationale, the endpoint list, and the statistical analysis plan. Writing the analysis plan before running the experiment — a practice called pre-registration in clinical research — removes the temptation to select endpoints post hoc.",
    },
    {
      type: "subheading",
      text: "Compound Specification Log",
    },
    {
      type: "paragraph",
      text: "Every compound used in a study warrants its own entry in a compound log. This should include: vendor name and order number, lot/batch number, stated molecular weight, purity (method: HPLC, MS, both), endotoxin level if tested, date received, storage condition on arrival, date opened, storage condition after opening, and calculated shelf life. If the compound requires special handling — light-sensitive, hygroscopic, or oxygen-sensitive — that should be flagged explicitly.",
    },
    {
      type: "list",
      items: [
        "Vendor + order/invoice number",
        "Lot/batch number (links to COA)",
        "Stated MW (used in reconstitution calculations)",
        "HPLC purity (%) and date of testing",
        "Mass confirmation: expected vs. observed m/z",
        "Endotoxin (EU/mg) — especially for in vitro work",
        "Date received / date opened",
        "Storage: temperature, light, moisture conditions",
        "Remaining quantity (update after each use)",
      ],
    },
    {
      type: "heading",
      text: "Reconstitution Documentation",
    },
    {
      type: "paragraph",
      text: "Reconstitution errors are a common source of irreproducibility in peptide research. Documenting the reconstitution process fully eliminates ambiguity when comparing results across experiments or troubleshooting unexpected outcomes.",
    },
    {
      type: "paragraph",
      text: "A reconstitution log entry should record: the date and time, the mass of lyophilized powder used (measured on calibrated balance, with balance calibration date noted), the diluent type (bacteriostatic water, sterile saline, DMSO, acetic acid, etc.), the volume of diluent added, the resulting concentration (calculated, with the calculation shown), and the final pH if relevant. For GLP-1 analogs and other aggregation-prone peptides, the reconstitution order — whether peptide was added to diluent or diluent to peptide — should also be recorded.",
    },
    {
      type: "subheading",
      text: "Example Reconstitution Calculation",
    },
    {
      type: "paragraph",
      text: "For 5 mg of BPC-157 (MW 1419.53 g/mol), to prepare a 1 mg/mL stock: add 5.0 mL bacteriostatic water. Record: '5.03 mg weighed (balance #B02, calibrated 2026-05-15), 5.03 mL BWI added at 09:14, target 1 mg/mL achieved at ~1.006 mg/mL, stored -80°C vial A1-A4.' The small precision detail matters: if a later dose calculation assumed exactly 1.000 mg/mL but stock was 1.006, that is a 0.6% systematic error — negligible in most cases, but traceable.",
    },
    {
      type: "heading",
      text: "Dose and Administration Logs",
    },
    {
      type: "paragraph",
      text: "For animal studies, a daily dosing log is essential. Entries should be timestamped, include the subject identifier (animal ID, cage number), the volume administered, the calculated dose in µg/kg or nmol/kg, the route (SC, IP, IV, intranasal), the injection site (for rotation tracking), and the observer's initials. Any deviation from protocol — missed dose, animal refusal, injection site reaction — should be noted with the reason and any corrective action.",
    },
    {
      type: "paragraph",
      text: "For cell-based studies, the dosing log should capture treatment plate identifiers, passage number of cells, seeding density and date, confluence at treatment, treatment concentration and volume added, treatment duration before endpoint assay, and incubation conditions (CO₂, temperature, humidity). These details are frequently absent from published methods sections, which is a primary reason for failed replications.",
    },
    {
      type: "heading",
      text: "COA Filing and Verification",
    },
    {
      type: "paragraph",
      text: "Every Certificate of Analysis received from a vendor should be filed with the corresponding compound log entry. But filing is only the first step — verification is what matters scientifically. At minimum, check that: (1) the lot number on the COA matches the vial label, (2) the MW on the COA matches the expected sequence MW (calculate from amino acid composition using a peptide calculator), (3) the purity method is stated and the raw chromatogram or spectrum is shown (not just a summary number), and (4) the endotoxin test method is specified (LAL kinetic turbidimetric or chromogenic — not a simple pass/fail without a threshold).",
    },
    {
      type: "paragraph",
      text: "Some vendors provide mass spec data as a single table of m/z values. Verify this independently: for a peptide with known MW, identify the expected [M+H]⁺, [M+2H]²⁺, and [M+3H]³⁺ ions. If the stated mass is 1419.53, the doubly-charged ion should appear at approximately 710.8 m/z. If the reported values don't match these expectations, the COA warrants further scrutiny.",
    },
    {
      type: "heading",
      text: "Adverse Event and Anomaly Logging",
    },
    {
      type: "paragraph",
      text: "Any unexpected observation — animal weight loss exceeding protocol thresholds, cell death in treated wells matching vehicle controls, anomalous ELISA values — should be logged immediately with a description, the time of observation, and a hypothesis for the cause. The natural temptation is to note such anomalies informally and move on; instead, formalize them in the notebook. If the anomaly turns out to be meaningful, you will have a timestamped record. If it turns out to be instrument error, your log shows due diligence.",
    },
    {
      type: "heading",
      text: "Digital vs. Physical Notebooks",
    },
    {
      type: "paragraph",
      text: "The scientific community has moved substantially toward electronic lab notebooks (ELNs), and for good reasons: searchability, backup, version history, and integration with instrument data exports. Popular options include Benchling, LabArchives, Notion (with structured templates), and local solutions like OneNote or Obsidian with systematic naming conventions. Whatever system is used, the key requirement is tamper-evidence: entries should be date-stamped and immutable after saving. ELNs with audit trails satisfy this; a Word document does not.",
    },
    {
      type: "paragraph",
      text: "For teams or institutions with IACUC or IRB oversight, the notebook (digital or physical) is the primary audit document. Reviewers look for: consistent documentation before and after protocol amendments, evidence that personnel had current training certifications, and a clear record of deviations from approved protocols. Maintaining documentation habits that satisfy these standards — even in informal research settings — is good practice for future work in regulated environments.",
    },
    {
      type: "heading",
      text: "Data Storage and Backup",
    },
    {
      type: "paragraph",
      text: "Raw data files — instrument exports, images, video recordings of behavioral assays — should be stored in original format alongside analysis files, never overwritten. A simple convention: a dated folder per experiment (e.g., 2026-06-07_BPC157_Tendon_Rat), with subdirectories for raw data, processed data, analysis scripts, and figures. Version control (git or similar) is strongly recommended for analysis scripts and R/Python notebooks. Images should retain original metadata (acquisition date, microscope settings) and not be adjusted beyond the brightness/contrast changes applied uniformly across all images in a dataset.",
    },
    {
      type: "paragraph",
      text: "Follow the 3-2-1 backup rule: three copies of data, on two different media, with one offsite (cloud or remote server). For work with any potential for publication, data should be retained for a minimum of 5–10 years post-publication. Institutional requirements may mandate longer periods.",
    },
    {
      type: "heading",
      text: "Why Documentation Matters for Peptide Research Specifically",
    },
    {
      type: "paragraph",
      text: "Peptide research has a reproducibility problem that documentation can partially address. A 2021 analysis of published preclinical peptide studies found that over 60% lacked sufficient methods detail for replication — missing vehicle composition, dosing frequency, or compound source. When researchers obtain contradictory results with the same compound, undocumented variables (reconstitution method, storage duration, animal age and sex, housing conditions) are often the hidden source of discordance. The discipline of complete documentation is not academic perfectionism — it is how the field builds reliable knowledge.",
    },
    {
      type: "disclaimer",
      text: "This article is for educational and research guidance purposes only. Documentation standards described here reflect best practices for preclinical and in vitro research. Researchers operating under IACUC, IRB, or GLP regulatory frameworks should follow the specific requirements of those frameworks, which may be more stringent than the general guidance provided here.",
    },
  ],
};
